Labshake search
Citations for Tocris :
1 - 50 of 175 citations for Cow Melanocyte Stimulating Hormone Receptor MC1R ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2019Quote: ... glycine receptors (GlyR) and GABAB receptors 10 μM (−)Bicuculline methiodide (Tocris Bioscience), 2 μM Strychnine hydrochloride (Tocris Bioscience ...
-
bioRxiv - Cell Biology 2020Quote: ... or blockers of receptors associated with OxPC activity including platelet activating factor receptor (WEB-2086, Tocris 2339), prostaglandin EP2 receptor (PF-04418948 ...
-
bioRxiv - Cell Biology 2020Quote: ... prostaglandin EP2 receptor (PF-04418948, Tocris 4814), CD36 [sulfosuccinimidyl oleate (SSO) ...
-
bioRxiv - Immunology 2019Quote: ... Adenosine receptor drugs were purchased from Tocris or Sigma Aldrich ...
-
bioRxiv - Immunology 2021Quote: ... and AT1 receptor antagonist Candesartan cilexetil (Tocris) were used in this study ...
-
bioRxiv - Immunology 2022Quote: ... the CCR3 receptor antagonist SB328437 (Tocris Bioscience) was added at a final concentration of 10 μM (41) ...
-
bioRxiv - Neuroscience 2023Quote: ... GABAB receptor antagonist CGP55845 (3 μM, Tocris), Na+ channel blocker tetrodotoxin (TTX ...
-
bioRxiv - Biochemistry 2023Quote: ... SKF81297 hydrobromide (D1-like receptor agonist, TOCRIS), quinpirole hydrochloride (D2-like receptor agonist ...
-
bioRxiv - Biochemistry 2023Quote: ... SCH 39166 (D1-like receptor antagonist, TOCRIS), raclopride (D2-like receptor antagonist ...
-
bioRxiv - Biochemistry 2023Quote: ... quinpirole hydrochloride (D2-like receptor agonist, TOCRIS), SCH 39166 (D1-like receptor antagonist ...
-
bioRxiv - Neuroscience 2019Quote: ... The receptor-selective agonists we used included SKF 81297 for D1-like receptors (10–50 µM; Tocris, Minneapolis, MN); quinpirole for D2-like receptors (10–50 µM ...
-
bioRxiv - Neuroscience 2022Quote: ... the AMPA/NMDA receptor agonist kynurenic acid (2 mM) and the GABA-A receptor antagonist picrotoxin (PTX; 100 uM, Tocris) were present ...
-
bioRxiv - Neuroscience 2020Quote: ... N-methyl D-aspartate (NMDA) receptors were blocked by the non-competitive NMDA receptor antagonist MK-801 (Tocris; 100 μM), co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris ...
-
bioRxiv - Neuroscience 2024Quote: ... BIBP-3226 (Y1 receptor antagonist, 1-2 μM), and BIIE-0246 (Y2 receptor antagonist, 1-2 μM) were obtained from Tocris.
-
bioRxiv - Developmental Biology 2020Quote: ... and TGFβ Receptor I Inhibitor II (25nM; Tocris were also used in this study ...
-
bioRxiv - Neuroscience 2020Quote: ... NMDA receptor blockers (D-AP5 50 μM, Tocris; (+)MK-801 10 μM ...
-
bioRxiv - Neuroscience 2021Quote: The Cck1 receptor (Cck1R) agonist A71623 (Tocris Biosciences) was suspended in 20mM PBS according to the manufacturer’s directions ...
-
bioRxiv - Neuroscience 2022Quote: ... the AMPA receptor blocker DNQX (10 mM, Tocris) was applied to the cortical surface in a subset of experiments ...
-
bioRxiv - Neuroscience 2023Quote: The general dopamine receptor antagonist flupenthixol dihydrochloride (Tocris) was prepared at a concentration of 100 μM in sterile 0.9% saline and frozen in aliquots that were thawed fresh immediately prior to use ...
-
bioRxiv - Neuroscience 2023Quote: ... and 50 μM NMDA receptor antagonist AP5 (Tocris). Data were filtered at 4 kHz and digitized at 20 kHz using Digidata 1550B and Clampex software (Molecular Devices) ...
-
bioRxiv - Immunology 2023Quote: ... AP-5 (25 nM, NMDA receptor blocker, Tocris), and actinomycin D (RNA polymerase inhibitor ...
-
bioRxiv - Neuroscience 2023Quote: ... AMPA receptor antagonist NBQX (20 μM, Tocris, 0373) and NMDA receptor antagonist APV (50 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... The dopamine D2-receptor antagonist raclopride (Tocris Bioscience) was used at a concentration of 100 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... CNQX (10 μM, Tocris; an AMPA receptor antagonist), glycine (10 μM ...
-
bioRxiv - Neuroscience 2024Quote: Oxytocin receptor antagonist (OTRA; L-368,899; Tocris 2641) was dissolved in saline 95% and DMSO 5% ...
-
bioRxiv - Neuroscience 2021Quote: ... To interfere with group I metabotropic glutamate receptor (mGluR) signaling we used bath application of either the mGlu1 receptor antagonist YM298198 (1 μM, Tocris, Germany) or the mGluR5 receptor antagonist MPEP (10 μM ...
-
bioRxiv - Cell Biology 2021Quote: Receptors were stimulated as follows: human Angiotensin 1 receptor (AT1R) with Angiotensin II (AngII; Tocris 4474-91-3, in measuring buffer), human β2 adrenergic receptor (β2ADR ...
-
bioRxiv - Cancer Biology 2020Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2021Quote: ... the NMDA receptor blocker D-AP5 (25 μM; Tocris), and the GABAA receptor blocker picrotoxin (50 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... and the GABAA receptor blocker picrotoxin (50 μM; Tocris).
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK ...
-
bioRxiv - Neuroscience 2019Quote: ... the AMPA/kainate receptor antagonist 50μM NBQX (Tocris Bioscience) (Chandler et al. ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 µM SR95531 (a blocker for GABAA receptors; Tocris) was used to verify the GABAergic nature of the currents recorded (data not shown) ...
-
bioRxiv - Neuroscience 2021Quote: ... the TrkB receptor antagonist ANA-12 (10 µM, Tocris), PKA inhibitor H89 (10 µM ...
-
Serotonin Modulates an Inhibitory Input to the Central Amygdala from the Ventral Periaqueductal GraybioRxiv - Neuroscience 2022Quote: ... 5HT2C receptor antagonist RS102221 (5 µM, Tocris, Minneapolis, MN) was added in the bath ...
-
bioRxiv - Neuroscience 2019Quote: ... quinpirole for D2-like receptors (10–50 µM; Tocris); and the D1/D2 receptor co-agonist SKF 83959 (10–50 µM ...
-
bioRxiv - Neuroscience 2022Quote: ... AP5 + CNQX cocktail (NMDA and AMPA receptor antagonists; Tocris) or aCSF as vehicle control ...
-
bioRxiv - Cancer Biology 2022Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2022Quote: ... adrenergic α1A receptor antagonist – RS17053 (40 μM, Tocris 0985); adrenergic α1B receptor antagonist – Chloroethylclonidine (30 μM ...
-
bioRxiv - Neuroscience 2022Quote: ... muscarinic acetylcholine receptor antagonist tiotropium bromide was from Tocris; 5-HT (100 μM ...
-
bioRxiv - Neuroscience 2022Quote: ... The CB1 receptor agonist WIN55,212-2 (WIN, Tocris #1038) was applied at a concentration of 1 µM as indicated ...
-
bioRxiv - Genomics 2023Quote: ... and the GABA-B receptor antagonist CGP55845 (Tocris #1246). Experiments with a series resistance of >15 MΩ or >20% change in series resistance were excluded from the final dataset ...
-
bioRxiv - Neuroscience 2023Quote: The GABAB-receptor antagonist CGP 54626 hydrochloride (Tocris Bioscience) was used at a concentration of 5 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... and NMDA receptor antagonist APV (50 μM, Tocris, 0106).
-
bioRxiv - Neuroscience 2023Quote: ... The GABAAR receptor agonist muscimol (10 μM, Tocris, 0289) was used to assess for functional GABAAR signaling ...
-
bioRxiv - Neuroscience 2019Quote: ... Receptor antagonists used this study included: GYKI-53655 (AMPAR; Tocris), LY341495 (group II mGluR ...
-
bioRxiv - Neuroscience 2021Quote: ... or the mGluR5 receptor antagonist MPEP (10 μM, Tocris, Germany) alone ...
-
bioRxiv - Neuroscience 2019Quote: ... the selective D3 receptor antagonist SB 27701A (5 µM; Tocris); the selective D4 receptor antagonist L-745 ...
-
bioRxiv - Bioengineering 2019Quote: ... TGF-β type I receptor inhibitor A83-01 500nM (Tocris), P38 inhibitor SB202190 10μM(Sigma-Aldrich) ...
-
bioRxiv - Cell Biology 2021Quote: A non-brain penetrable Y1 receptor antagonist BIBO3304 (Tocris Bioscience) was prepared in Milli Q water at a concentration of 1 mg/ml ...